The Arg16Gly polymorphism of the β2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans

Journal of Physiology

Volumn 574, Issue 3, 2006, Pages 947-954

  Snyder, Eric M ^a   Turner, Stephen T ^a   Joyner, Michael J ^a   Eisenach, John H ^a   Johnson, Bruce D ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; GLYCINE; SODIUM CHLORIDE; SODIUM ION; SODIUM;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; NATRIURESIS; NORMAL HUMAN; PRIORITY JOURNAL; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; URINALYSIS; VASODILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; METABOLISM; URINE; HOMOZYGOTE; KIDNEY TUBULE ABSORPTION; SODIUM URINE LEVEL;

ADULT; ARGININE; FEMALE; GLYCINE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-2; SODIUM; SODIUM CHLORIDE;

EID: 33746238423     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.107672     Document Type: Article

References (40)

1. Bell C, Monahan KD, Donato AJ, Hunt BE, Seals DR & Beck KC (2003). Use of acetylene breathing to determine cardiac output in young and older adults. Med Sci Sports Exerc 35, 58-64.
2. Bittner HB, Chen EP, Milano CA, Lefkowitz RJ & Van Trigt P (1997). Functional analysis of myocardial performance in murine hearts overexpressing the human beta 2-adrenergic receptor. J Mol Cell Cardiol 29, 961-967.
3. Borg GAV (1982). A category scale with ratio properties for intermodal and interindividual comparisons. In Psychophysial Judgement and the Process of Perception ed. Geissler HG & Petzold P, pp. 25-34. Veb Deutsche Verlag Wissen Schaften, Berlin.
4. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST & Boerwinkle E (2000). Positional genomic analysis identifies the beta2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101, 2877-2882.
5. Bristow MR, Hershberger RE, Port JD, Minobe W & Rasmussen R (1989). Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium. Mol Pharmacol 35, 295-303.
6. Brodde OE (1991). Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43, 203-242.
7. Chen X, Eaton DC & Jain L (2001). Alveolar epithelial ion and fluid transport B-adrenergic regulation of amiloride-sensitive lung sodium channels. Am J Physiol Lung Cell Mol Physiol 282, L609-L620.
8. Chruscinski AJ, Rohrer DK, Schauble E, Desai KH, Bernstein D & Kobilka BK (1999). Targeted disruption of the beta2 adrenergic receptor gene. J Biol Chem 274, 16694-16700.
9. +-conducting ion channels in the kidney. Am J Physiol 271, C1303-C1315.
10. DiBona GF & Kopp UC (1997). Neural control of renal function. Physiol Rev 77, 75-197.
11. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM & Wood AJ (2001). The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345, 1030-1035.
12. Eisenach JH, Barnes SA, Pike TL, Sokolnicki LA, Masuki S, Dietz NM, Rehfeldt KH, Turner ST & Joyner MJ (2005). The Arg16/Gly beta2-adrenergic receptor polymorphism alters the cardiac output response to isometric exercise. J Appl Physiol 99, 1776-1781.
13. 2-adrenergic receptor polymorphism modulate cardiovascular function in humans. J Physiol 574, 955-965.
14. Eisenach JH, McGuire AM, Schwingler RM, Turner ST & Joyner MJ (2004). The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise. Physiol Genomics 16, 323-328.
15. Gaballa MA, Peppel K, Lefkowitz RJ, Aguirre M, Dolber PC, Pennock GD, Koch WJ & Goldman S (1998). Enhanced vasorelaxation by overexpression of beta 2-adrenergic receptors in large arteries. J Mol Cell Cardiol 30, 1037-1045.
16. Gavoric VD, Joyner MJ, Dietz NM, Boerwinkle E & Turner ST (2003). Beta2-adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol 546, 583-589.
17. Grandy SA, Denovan-Wright EM, Ferrier GR & Howlett SE (2004). Overexpression of human beta2-adrenergic receptors increases gain of excitation-contraction coupling in mouse ventricular myocytes. Am J Physiol Heart Circ Physiol 287, H1029-H1038.
18. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft FC, Hoehe MR & Skrabal F (1999). Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 33, 1425-1430.
19. Green SA, Cole G, Jacinto M, Innis M & Liggett SB (1993). A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268, 23116-23121.
20. Green SA, Turki J, Hall IP & Liggett SB (1995). Implications of genetic variability of human beta 2-adrenergic receptor structure. Pulm Pharmacol 8, 1-10.
21. Green SA, Turki J, Innis M & Liggett SB (1994). Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33, 9414-9419.
22. Herrmann SM, Nicaud V, Tiret L, Evans A, Kee F, Ruidavets JB, Arveiler D, Luc G, Morrison C, Hoehe MR, Paul M & Cambien F (2002). Polymorphisms of the beta2-adrenoceptor (ADRB2) gene and essential hypertension: The ECTIM and PEGASE studies. J Hypertens 20, 229-235.
23. Iaccarino G, Cipolletta E, Fiorillo A, Annecchiarico M, Ciccarelli M, Cimini V, Koch WJ & Trimarco B (2002). Beta2-adrenergic receptor gene delivery to the endothelium corrects impaired adrenergic vasorelaxation in hypertension. Circulation 106, 349-355.
24. Johnson BD, Beck KC, Proctor DN, Miller J, Dietz NM & Joyner MJ (2000). Cardiac output during exercise by the open circuit acetylene washin method: Comparison with direct Fick. J Appl Physiol 88, 1650-1658.
25. Kerem E, Bistritzer T, Hanukoglu A, Hofmann T, Zhou Z, Bennett W, MacLaughlin E, Barker P, Nash M, Quittell L, Boucher R & Knowles MR (1999). Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 341, 156-162.
26. Koepke JP & Dibona GF (1986). Central adrenergic receptor control of renal function in conscious hypertensive rats. Hypertension 8, 133-141.
27. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL & Spertus JA (2005). Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. JAMA 294, 1526-1533.
28. Naslund T, Silberstein DJ, Merrell WJ, Nadeau JH & Wood AJ (1990). Low sodium intake corrects abnormality in beta-receptor-mediated arterial vasodilation in patients with hypertension: Correlation with beta-receptor function in vitro. Clin Pharmacol Ther 48, 87-95.
29. O'Donnell SR & Wanstall JC (1984). Beta-1 and beta-2 adrenoceptor-mediated responses in preparations of pulmonary artery and aorta from young and aged rats. J Pharmacol Exp Ther 228, 733-738.
30. Planes C, Blot-Chabaud M, Matthay MA, Couette S, Uchida T & Clerici C (2002). Hypoxia and beta 2-agonists regulate cell surface expression of the epithelial sodium channel in native alveolar epithelial cells. J Biol Chem 277, 47318-47324.
31. Pradervand S, Barker PM, Wang Q, Ernst SA, Beermann F, Grubb BR, Burnier M, Schmidt A, Bindels RJ, Gatzy JT, Rossier BC & Hummler E (1999). Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel. Proc Natl Acad Sci U S A 96, 1732-1737.
32. Sealey JE (1991). Plasma renin activity and plasma prorenin assays. Clin Chem 37, 1811-1819.
33. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Schambelan M et al. (1994). Liddle's syndrome: Heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 79, 407-414.
34. Snyder EM, Beck KC, Dietz NM, Eisenach JH, Joyner MJ, Turner ST & Johnson BD (2005 a). Arg16Gly polymorphism of the beta-2 adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans. J Physiol 571, 121-130.
35. Snyder EM, Joyner MJ, Turner ST & Johnson BD (2005 b). Blood pressure variation in healthy humans: A possible interaction with beta-2 adrenergic receptor genotype and renal epithelial sodium channels. Med Hypotheses 65, 296-299.
36. Snyder EM, Hulsebus ML, Turner ST, Joyner MJ & Johnson BD (2006). Genotype related differences in beta-2 adrenergic receptor density influence cardiac function. Med Sci Sports Exerc 38 (5), 882-886.
37. + channel to the cell surface. J Clin Invest 105, 45-53.
38. Tang W, Devereux RB, Kitzman DW, Province MA, Leppert M, Oberman A, Hopkins PN & Arnett DK (2003). The Arg16Gly polymorphism of the beta2-adrenergic receptor and left ventricular systolic function. Am J Hypertens 16, 945-951.
39. Wallace DP, Reif G, Hedge AM, Thrasher JB & Pietrow P (2004). Adrenergic regulation of salt and fluid secretion in human medullary collecting duct cells. Am J Physiol Renal Physiol 287, F639-F648.
40. Wallace DP, Rome LA, Sullivan LP & Grantham JJ (2001). cAMP-dependent fluid secretion in rat inner medullary collecting ducts. Am J Physiol Renal Physiol 280, F1019-F1029.